Report      Database

    Global Molecular Diagnostics Market & Future Forecast 2010 - 2014

    Date: 07 Jul, 2011              Type: Diagnostics              Pages: 92

    Global Molecular Diagnostics Market & Future Forecast 2010 - 2014
    • Electronic Access - Single User License
      $1,200.00
    • CD-ROM Mail Delivery
      $1,300.00
    • Hard-copy Mail Delivery
      $1,300.00
    • Electronic Access - Multi User License
      $1,800.00

    Global Molecular Diagnostics - Market Overview

     
    The global molecular diagnostics market is witnessing a period of profound growth. The growth is coming from different regions and markets. The various application and technological sub-segments of molecular diagnostics are also giving the market a big push. The increase in the aging population and incidences of various chronic diseases are driving the demand of molecular diagnostics world over. The industry is getting a push from every side and many factors collectively are fuelling the growth in this industry.
     
    Molecular diagnostics is a vital and dynamic field in which yesterday’s new technologies and platforms are today becoming populated with novel, diverse, and useful content. Growing with a CAGR of 19 percent global molecular diagnostics market is expected to reach US$ 15 Billion by 2014.The fastest growing segment is infectious disease with 21% market share as the dominant segment. The next fastest growing segment is oncology testing due to rising cases of cancer patients .The future growth is expected to come from genetic testing, blood screening testing and neurological testing.
     
    Geographically, the US and EMEA markets are the most advanced in terms of adoption of molecular testing and make up the majority of the existing market. However, Japanese molecular diagnostics market is promising with the ageing population and a declining birth rate is putting the whole Japanese healthcare system under pressure. Under such circumstances, the role of preventive medical care is increasingly important. China and India molecular diagnostics market is one of the lucrative markets to rollout the diagnosis business. As with the rapid advancement Chinese and Indian economy has dramatically increased the purchasing power of a growing segment of the populace, which coupled with an emerging mindset toward wellness, preventive medicine, and access to cutting-edge products and services and makes the future outlook extremely positive for this very exciting new field in clinical care. The provision of new and cutting-edge molecular tests will surely be followed by greater affordability as prices come down due to return on investment, competition, and technology advancement.
     
    Report Details
     
    “Global Molecular Diagnostics Market & Future Forecast 2010 - 2014” report published by Renub Research provides an in-depth analysis of the past, present and future prospects. The report has been researched at source globally and features latest available data covering:


     •    Global Molecular Diagnostics Market (2008 to 2014)
    •    Top 8 application wise molecular diagnostics (Infectious Disease Testing, Blood Screening Testing, Oncology Testing, Genetic Testing, Tissue Typing Testing, Cardiovascular Disease Testing, Neurological Testing and Food Pathogen Detection Testing) data  of Past, Present and
            Future Market (2008 to 2014)
    •    Top 7 technological wise molecular diagnostics (PCR based tests, PCR related technologies, Non-PCR tests, FISH & Innovation testing, Biochips, Biosensor & Other technologies) data of Past, Present and Future Market (2008 to 2014)
    •    Top 9 Countries (USA, Europe the Middle East & Africa , Japan, China, India, Germany, Brazil,Mexico and South Korea) data of  Past, Present and Future Market 
    •    Mergers and Acquisitions in the molecular diagnostics market    
    •    Key drivers of growth in the molecular diagnostics market
    •    Key Players in the molecular diagnostics market
     
    Research Highlights
     
    •    Globally, Molecular Diagnostics market is expected to  reach  US$ 15 Billion by 2014 
    •    Infectious disease testing dominates the molecular diagnostics market with more than 21% market share in 2010 
    •    Oncology and infectious disease testing sectors are likely growth leaders in the molecular diagnostics market
    •    Blood Screening & Genetic testing will have a combined market share of 26% by 2014
    •    Biochips market is expected to cross US$ 3 Billion by 2014
    •    Fish & Innovation testing is expected to capture more than 16% market share by 2014
    •    USA is expected to have more than US$ 6 Billion molecular diagnostics market by 2014
     
    Key Players Analyzed 
     
    This section covers the key facts about the major players in molecular diagnostics market. The key players analyzed in this section are Roche, Abbott, Bayer AG, Qiagen, Gen-Probe, Becton Dickinson and Company, bioMérieux, Myriad Genetics, Inc., Celera Corporation.
     
    Data Sources 
     
    Information and data in this report has been collected from various printable and non-printable sources like Trade Journals, White papers, Online paid databases, News websites, Government Agencies, Magazines, Newspapers and Trade associations. 

    1.    Executive Summary
     
    2.    Global – Molecular Diagnostics Market & Market Shares (Application wise and Technological wise) 

    2.1    Molecular Diagnostics Market & Future Forecast
    2.2    Molecular Diagnostics Market Share & Future Forecast (Application Segment) 
    2.3    Molecular Diagnostics Market Share & Future Forecast (Technologies Segment) 
     
    3.    Molecular Diagnostics Market (Application Segment) – 2008 to 2014
    3.1    Infectious Disease Testing Market
    3.1.1    Virology Testing Market
    3.1.2    Haemagglutination-Inhibition Test (HAI) Testing
    3.1.3    Critical Care Infectious Testing Market
    3.2    Blood Screening Market
    3.3    Genetic Testing Market
    3.4    Oncology Testing Market
    3.5    Tissue Typing (HLA Testing) Market
    3.6    Cardiovascular Disease Testing Market
    3.7    Neurological Disorders Testing Market
    3.8    Food Pathogen Detection Testing Market
     
    4.    Molecular Diagnostics Market (Technologies Segment) – 2008 to 2014
    4.1    PCR Based Test Market
    4.2    PCR Related Technologies Market
    4.3    Non-PCR Test Market
    4.4    Fish & Innovations Testing Market (Fluorescent in-situ hybridization) 
    4.5    Biochips Market
    4.6    Biosensors
    4.7    Other Technologies Market
     
    5.    Geographical Distribution - Molecular Diagnostics Market (2008 to 2014) 
    5.1    United States Molecular Diagnostics Market
    5.2    Europe, the Middle East & Africa (EMEA) Molecular Diagnostics Market
    5.3    Germany Molecular Diagnostics Market
    5.4    India Molecular Diagnostics Market
    5.5    China Molecular Diagnostics Market
    5.6    Japan Molecular Diagnostics Market
    5.7    Brazil Molecular Diagnostics Market
    5.8    Mexico Molecular Diagnostics Market
    5.9    South Korea Molecular Diagnostics Market
     
    6.    Global Mergers & Acquisitions Deals in the Molecular Diagnostics Sector
     
    7.    Key Drivers of Growth in Global Molecular Diagnostics Market

    7.1    Aging of the population
    7.2    Re-Emergence of infectious threats (drug resistant TB, new strains of HIV, H1N1 & other flu)
    7.3    Scientific and Technological Advancements
     
    8.    Challenges
    8.1    Reimbursement
    8.2    The need for new Biomarker Assays
    8.3    Regulatory Environment
    8.4    Awareness and Acceptance
     
    9.    Key Players
    9.1    Roche
    9.2    Abbott Laboratories
    9.3    Qiagen
    9.4    BD (Becton, Dickinson and Company) 
    9.5    biomerieux
    9.6    Bayer AG
    9.7    Gen-Probe
    9.8    Myriad Genetics, Inc
    9.9    Celera Corporation
    9.10    Beckman Coulter

    List of Figures:
     
    Figure 2 1: Global   Molecular Diagnostics Market (Million US$), 2008   2010
    Figure 2 2: Global   Forecast for Molecular Diagnostics Market (Million US$), 2011  2014
    Figure 2 3: Global   Segments of Molecular Diagnostics Market Share (Percent), 2008   2010
    Figure 2 4: Global   Forecast for Segments of Molecular Diagnostics Market Share (Percent), 2011   2014
    Figure 2 5: Global   Molecular Diagnostics Market Share Technologies wise (Percent), 2008   2010
    Figure 2 6: Global   Forecast for Molecular Diagnostics Market Share Technologies wise (Percent), 2011   2014
    Figure 3 1: Global   Infectious Disease Testing Market (Million US$), 2008   2010
    Figure 3 2: Global   Forecast for Infectious Disease Testing Market (Million US$), 2011   2014
    Figure 3 3: Global   Virology Testing Market (Million US$), 2007   2010
    Figure 3 4: Global   Forecast for Virology Testing Market (Million US$), 2011   2014
    Figure 3 5: Global   HAI Testing Market (Million US$), 2008   2010
    Figure 3 6: Global   Forecast for HAI Testing Market (Million US$), 2011   2014
    Figure 3 7: Global   Critical Care Infectious Testing Market (Million US$), 2008   2010
    Figure 3 8: Global   Forecast for Critical Care Infectious Testing Market (Million US$), 2011   2014
    Figure 3 9: Global   Blood Screening Market (Million US$), 2007   2010
    Figure 3 10: Global   Forecast for Blood Screening Market (Million US$), 2011   2014
    Figure 3 11: Global   Genetic Testing Market (Million US$), 2007   2010
    Figure 3 12: Global   Forecast for Genetic Testing Market (Million US$), 2011   2014
    Figure 3 13: Global   Oncology Market (Million US$), 2007   2010
    Figure 3 14: Global   Forecast for Oncology Market (Million US$), 2011   2014
    Figure 3 15: Global   Tissue Typing Market (Million US$), 2008   2010
    Figure 3 16: Global   Forecast for Tissue Typing Market (Million US$), 2011   2014
    Figure 3 17: Global   Cardiovascular Disease Testing Market (Million US$), 2005   2010
    Figure 3 18: Global   Forecast for Cardiovascular Disease Testing Market (Million US$), 2011   2014
    Figure 3 19: Global   Neurological Disorders Testing Market (Million US$), 2005   2010
    Figure 3 20: Global   Forecast for Neurological Disorders Testing Market (Million US$), 2011   2014
    Figure 3 21: Global   Food Pathogen Detection Testing Market (Million US$), 2005   2010
    Figure 3 22: Global   Forecast for Food Pathogen Detection Testing Market (Million US$), 2011   2014
    Figure 4 1: Global   PCR Based Test Market (Million US$), 2005   2010
    Figure 4 2: Global   Forecast for PCR Based Test Market (Million US$), 2011   2014
    Figure 4 3: Global   PCR Related Technologies Market (Million US$), 2005   2010
    Figure 4 4: Global   Forecast for PCR Related Technologies Market (Million US$), 2011   2014
    Figure 4 5: Global   Non-PCR Test Market (Million US$), 2005   2010
    Figure 4 6: Global   Non-PCR Test Market (Million US$), 2011   2014
    Figure 4 7: Global   Fish & Innovations Market (Million US$), 2005   2010
    Figure 4 8: Global   Forecast for Fish & Innovations Market (Million US$), 2011   2014
    Figure 4 9: Global   Biochips/ Microarrays Market (Million US$), 2005   2010
    Figure 4 10: Global   Forecast for Biochips/Micrroarrays Market (Million US$), 2011   2014
    Figure 4 11: Global   Biosensors Market (Million US$), 2005   2010
    Figure 4 12: Global   Forecast for Biosensors Market (Million US$), 2011   2014
    Figure 4 13: Global   Other Technologies Market (Million US$), 2005   2010
    Figure 4 14: Global   Forecast for Other Technologies Market (Million US$), 2011   2014
    Figure 5 1: US   Molecular Diagnostics Market (Million US$), 2002   2010
    Figure 5 2: US   Forecast for Molecular Diagnostics Market (Million US$), 2011   2014
    Figure 5 3: EMEA   Molecular Diagnostics Market (Million US$), 2007   2010
    Figure 5 4: EMEA   Forecast for Molecular Diagnostics Market (Million US$), 2011   2014
    Figure 5 5: Germany   Molecular Diagnostics Market (Million US$), 2009   2010
    Figure 5 6: Germany   Forecast for Molecular Diagnostics Market (Million US$), 2011   2014
    Figure 5 7: India   Molecular Diagnostics Market (Million INR), 2006   2010
    Figure 5 8: India   Forecast for Molecular Diagnostics Market (Million INR), 2011   2014
    Figure 5 9: China   Molecular Diagnostics Market (Million US$), 2004, 2007   2010
    Figure 5 10: China   Forecast for Molecular Diagnostics Market (Million US$), 2011   2014
    Figure 5 11: Japan   Molecular Diagnostics Market (Million US$), 2007   2010
    Figure 5 12: Japan   Forecast for Molecular Diagnostics Market (Million US$), 2011   2014
    Figure 5 13: Brazil   Molecular Diagnostics Market (Million US$), 2007   2010
    Figure 5 14: Brazil   Forecast for Molecular Diagnostics Market (Million US$), 2011   2014
    Figure 5 15: Mexico   Molecular Diagnostics Market (Million US$), 2007   2010
    Figure 5 16: Mexico   Forecast for Molecular Diagnostics Market (Million US$), 2011   2014
    Figure 5 17: South Korea   Molecular Diagnostics Market (Million US$), 2005   2010
    Figure 5 18: South Korea   Forecast for Molecular Diagnostics Market (Million US$), 2011   2014
    Figure 7 1: Global   Population Aged 60 or Over: World and Development Regions, 1950, 1975, 2009, 2025 & 2050
    Figure 7 2: Old age Dependency Ratio: Major Areas, 2009 & 2050

     
    List of Tables:
     
    Table 6 1: Global   Mergers & Acquisitions Deals in the Molecular Diagnostics Sector (Million US$) 2006   2010
    Table 7 1: Global   Population Aged 60 or Over, 65 or Over and 80 Or Over By Sex (Thousands): World, Major Areas and Regions, 2009
    Table 9 1: Roche   Key Financials (Million US$) 2008   2010
    Table 9 2: Abbott Laboratories   Key Financials (Million US$) 2008   2010
    Table 9 3: Qiagen   Key Financials (Million US$) 2008   2010
    Table 9 4: BD (Becton, Dickinson and Company)   Key Financials (Million US$) 2008   2010
    Table 9 5: Biomerieux   Key Financials (Million US$) 2008   2010
    Table 9 6: Bayer AG   Key Financials (Million US$) 2008   2010
    Table 9 7: Gen Probe   Key Financials (Million US$) 2008   2010
    Table 9 8: Myriad Genetics, Inc. Key Financials (Million US$) 2008   2010
    Table 9 9: Celera Corporation   Key Financials (Million US$), 2008   2010
    Table 9 10: Beckman Coulter   Key Financials (Million US$) 2008   2010


    Related Products

    • Dummy Data2 Dummy Title2 raghu


      Dummy Data2 Dummy Title2 raghu
      Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillu...
      Date: 07 Nov, 2017
      Type: Healthcare
      Pages: 0
      Price: $0.00